Eli Lilly and Company (India) Pvt Ltd - Company Review
Eli Lilly and Company (India) Pvt Ltd - Company ReviewSummary
Eli Lilly and Company (India) Pvt Ltd (Eli Lilly), a subsidiary of Eli Lilly and Company is a drug company that manufactures medicines. The company offers pharmaceutical products for the therapeutic areas such as diabetes, cancer, osteoporosis, cardiovascular disorders and growth-hormone deficiency. Its pharmaceutical products comprise insulin lispros, soluble insulin injection, isophane insulin injection, biphasic isophane insulin injection, pemetrexed disodium, and others. Eli Lilly conducts research and development to develop new products. The company concentrates on personalized medicine. It markets its products through a network of distributors in domestic and overseas markets. Eli Lilly is headquartered in Gurgaon, Haryana, India.
This comprehensive company report of Eli Lilly and Company (India) Pvt Ltd provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.